Which has the lower trailing P/E, AMGN or NVO?

NVO has the lower trailing P/E: AMGN trades at 23.35 and NVO at 10.48. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, AMGN or NVO?

Over the past five years, NVO grew revenue faster — AMGN at a 8.39% CAGR versus NVO at 19.76%.

Does AMGN or NVO pay a bigger dividend?

AMGN yields 2.63% and NVO yields 4.17% based on trailing dividends and the latest price.

Is AMGN or NVO more profitable?

NVO runs the higher net margin — AMGN at 22.93% versus NVO at 35.33%.

How have AMGN and NVO total returns compared?

Over the past 10 years, AMGN delivered 11.80% and NVO delivered 9.46% annualized total return. Past performance doesn't predict future results.

Amgen Inc. (AMGN) vs Novo Nordisk A/S (NVO)

A side-by-side comparison of Amgen Inc. and Novo Nordisk A/S across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

AMGN

Amgen Inc.

$202.74B

$375.65HealthcareDelayed quote: Sep 15, 2026, 4:00 PM EDT

NVO

Novo Nordisk A/S

$188.86B

$42.53HealthcareDelayed quote: Sep 15, 2026, 4:00 PM EDT

Total return — AMGN vs NVO

growth of $100 · dividends reinvested · last 10y

AMGN +197.8% (+11.5%/yr)NVO +135.8% (+9.0%/yr)AMGN compounded faster over this window

AMGN NVO

AMGN vs NVO: by the numbers

•AMGN is the larger company ($202.74B vs $188.86B market cap).
•NVO trades at the lower trailing earnings multiple (10.48 vs 23.35 P/E), one valuation lens rather than an overall verdict.
•NVO converts more revenue to profit (35.33% vs 22.93% net margin).
•NVO grew revenue faster over the past five years (19.76% vs 8.39% CAGR).
•NVO pays the higher dividend yield (4.17% vs 2.63%).

Metrics side by side

Valuation

Metric	AMGN	NVO
P/E ratio	23.35	10.48
Forward P/E	16.28	N/A
P/S ratio	5.32	3.70
P/B ratio	17.35	5.60
EV / EBITDA	N/A	7.76
FCF yield	5.02%	3.94%

Profitability

Metric	AMGN	NVO
Gross margin	72.65%	80.64%
Operating margin	33.18%	43.10%
Net margin	22.93%	35.33%
ROE	74.80%	53.50%
ROIC	14.22%	30.21%

Dividends

Metric	AMGN	NVO
Dividend yield	2.63%	4.17%
Payout ratio	61.78%	44.27%

Growth (annualized)

Metric	AMGN	NVO
Revenue CAGR (5Y)	8.39%	19.76%
EPS CAGR (5Y)	2.94%	19.59%
FCF CAGR (5Y)	-3.91%	-1.45%
Total return CAGR (5Y)	15.58%	-0.65%

Frequently asked

Which has the lower trailing P/E, AMGN or NVO?: NVO has the lower trailing P/E: AMGN trades at 23.35 and NVO at 10.48. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, AMGN or NVO?: Over the past five years, NVO grew revenue faster — AMGN at a 8.39% CAGR versus NVO at 19.76%.
Does AMGN or NVO pay a bigger dividend?: AMGN yields 2.63% and NVO yields 4.17% based on trailing dividends and the latest price.
Is AMGN or NVO more profitable?: NVO runs the higher net margin — AMGN at 22.93% versus NVO at 35.33%.
How have AMGN and NVO total returns compared?: Over the past 10 years, AMGN delivered 11.80% and NVO delivered 9.46% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AMGN analysis Full NVO analysis Interactive comparison tool

Dig into the metrics

Amgen P/E ratio Novo Nordisk A/S P/E ratio Amgen dividend yield Novo Nordisk A/S dividend yield Amgen ROE Novo Nordisk A/S ROE Amgen operating margin Novo Nordisk A/S operating margin Amgen revenue growth Novo Nordisk A/S revenue growth Amgen free cash flow Novo Nordisk A/S free cash flow

Amgen & Novo Nordisk A/S appear in these rankings

Highest Dividend Yield Stocks Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.